How to handle off-label prescriptions of rupatadine, a second-generation antihistamine and PAF antagonist: a review

The off-label use of second-generation antihistamines, used outside of the formal indications authorized by regulatory authorities, in different age groups, doses or in special populations, is very common for many allergic, autoimmune and dermatological diseases. The off-label use of rupatadine (a s...

Full description

Bibliographic Details
Main Authors: Iñaki Izquierdo, Laia Casas, Susana Cabrera, Alberto Fernandez
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2024-01-01
Series:Drugs in Context
Subjects:
Online Access:https://www.drugsincontext.com/how-to-handle-off-label-prescriptions-of-rupatadine-a-second-generation-antihistamine-and-paf-antagonist-a-review/
_version_ 1797352235026350080
author Iñaki Izquierdo
Laia Casas
Susana Cabrera
Alberto Fernandez
author_facet Iñaki Izquierdo
Laia Casas
Susana Cabrera
Alberto Fernandez
author_sort Iñaki Izquierdo
collection DOAJ
description The off-label use of second-generation antihistamines, used outside of the formal indications authorized by regulatory authorities, in different age groups, doses or in special populations, is very common for many allergic, autoimmune and dermatological diseases. The off-label use of rupatadine (a second-generation antihistamine with PAF antagonist activity) in these conditions is reviewed here, including in combination with immunotherapy in the treatment of food allergy or allergic rhinitis, at high doses in chronic urticaria, and with prescriptions of less common but challenging conditions such as skin pruritus or mast cell activation disorders like mastocytosis. Rupatadine use is reviewed herein to confirm if its off-label management is supported by well-designed clinical trials or by published real-world cases. This review will contribute to increasing compliance and achieving better results in clinical practice. Off-label use of rupatadine should be left to the discretion of the prescribing healthcare professional after careful clinical evaluation.
first_indexed 2024-03-08T13:12:20Z
format Article
id doaj.art-7c292e323ad043fa9ace1a95ba706be7
institution Directory Open Access Journal
issn 1740-4398
language English
last_indexed 2024-03-08T13:12:20Z
publishDate 2024-01-01
publisher BioExcel Publishing Ltd
record_format Article
series Drugs in Context
spelling doaj.art-7c292e323ad043fa9ace1a95ba706be72024-01-18T11:09:41ZengBioExcel Publishing LtdDrugs in Context1740-43982024-01-011311010.7573/dic.2023-9-5How to handle off-label prescriptions of rupatadine, a second-generation antihistamine and PAF antagonist: a reviewIñaki IzquierdoLaia CasasSusana CabreraAlberto FernandezThe off-label use of second-generation antihistamines, used outside of the formal indications authorized by regulatory authorities, in different age groups, doses or in special populations, is very common for many allergic, autoimmune and dermatological diseases. The off-label use of rupatadine (a second-generation antihistamine with PAF antagonist activity) in these conditions is reviewed here, including in combination with immunotherapy in the treatment of food allergy or allergic rhinitis, at high doses in chronic urticaria, and with prescriptions of less common but challenging conditions such as skin pruritus or mast cell activation disorders like mastocytosis. Rupatadine use is reviewed herein to confirm if its off-label management is supported by well-designed clinical trials or by published real-world cases. This review will contribute to increasing compliance and achieving better results in clinical practice. Off-label use of rupatadine should be left to the discretion of the prescribing healthcare professional after careful clinical evaluation.https://www.drugsincontext.com/how-to-handle-off-label-prescriptions-of-rupatadine-a-second-generation-antihistamine-and-paf-antagonist-a-review/allergic rhinitisantihistaminechronic spontaneous urticariamast cell activation disordersoff-label useplatelet-activating factorpruritusrupatadine
spellingShingle Iñaki Izquierdo
Laia Casas
Susana Cabrera
Alberto Fernandez
How to handle off-label prescriptions of rupatadine, a second-generation antihistamine and PAF antagonist: a review
Drugs in Context
allergic rhinitis
antihistamine
chronic spontaneous urticaria
mast cell activation disorders
off-label use
platelet-activating factor
pruritus
rupatadine
title How to handle off-label prescriptions of rupatadine, a second-generation antihistamine and PAF antagonist: a review
title_full How to handle off-label prescriptions of rupatadine, a second-generation antihistamine and PAF antagonist: a review
title_fullStr How to handle off-label prescriptions of rupatadine, a second-generation antihistamine and PAF antagonist: a review
title_full_unstemmed How to handle off-label prescriptions of rupatadine, a second-generation antihistamine and PAF antagonist: a review
title_short How to handle off-label prescriptions of rupatadine, a second-generation antihistamine and PAF antagonist: a review
title_sort how to handle off label prescriptions of rupatadine a second generation antihistamine and paf antagonist a review
topic allergic rhinitis
antihistamine
chronic spontaneous urticaria
mast cell activation disorders
off-label use
platelet-activating factor
pruritus
rupatadine
url https://www.drugsincontext.com/how-to-handle-off-label-prescriptions-of-rupatadine-a-second-generation-antihistamine-and-paf-antagonist-a-review/
work_keys_str_mv AT inakiizquierdo howtohandleofflabelprescriptionsofrupatadineasecondgenerationantihistamineandpafantagonistareview
AT laiacasas howtohandleofflabelprescriptionsofrupatadineasecondgenerationantihistamineandpafantagonistareview
AT susanacabrera howtohandleofflabelprescriptionsofrupatadineasecondgenerationantihistamineandpafantagonistareview
AT albertofernandez howtohandleofflabelprescriptionsofrupatadineasecondgenerationantihistamineandpafantagonistareview